29 results
PRE 14A
SYBX
Synlogic Inc
21 Apr 23
Preliminary proxy
4:00pm
Biologics and previously served as President of Research and Development at Turnstone Biologics, where he led the build out of the cancer immunotherapy R&D organization
8-K
EX-99.2
SYBX
Synlogic Inc
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am
Revenue $0.6 M - 1.8 M 0.5 M R&D Expenses $11.9 M $11.4 M $47.1 M $47.5 M G&A Expenses $3.9 M $3.3 M $15.4 M $13.5 M Net Loss $(15.1 M) $(14.6 M) $(60.6 M
8-K
EX-99.2
dnu6j
10 Nov 21
Synlogic Reports Third Quarter Financial Results and Provides Business Update
8:31am
8-K
EX-99.2
6c0488 wd
20 Sep 21
Regulation FD Disclosure
8:01am
8-K
EX-99.3
qzvpg4m9ngd5 7r1ji
12 Aug 21
Synlogic Reports Second Quarter Financial Results and Provides Business Update
10:18am
8-K
EX-99.2
vkek0w079silr
12 Aug 21
Synlogic Reports Second Quarter Financial Results and Provides Business Update
10:18am
8-K
EX-99.2
lxr my9imx1
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.3
g83a7w yjbtgctkvs
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
p5nnsvz
10 Feb 21
Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors
9:04am
8-K
EX-99.1
co1bl
10 Feb 21
Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors
9:04am
8-K
EX-99.3
afl5gdm oo
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.1
3dz3po6 rcdz
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.2
boq4k0
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.1
3u13c5 vcv1e9pq
27 May 20
Regulation FD Disclosure
8:10am
8-K
EX-99.1
d6gz bbq9bp
8 May 20
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
7:15am